Skip to main content

Table 2 Characteristics of IVF-ICSI stimulation cycles

From: Reproductive outcomes in women with unicornuate uterus undergoing in vitro fertilization: a nested case-control retrospective study

  Unicornuate uterus Control p-value
n = 342 women n = 1026 women
Number of IVF/ICSI cycles, n 342 1026  
 ICSI, n (%) 26.3% (90/342) 30.5% (310/1026) p = 0.146
 GnRH agonist protocol, % (n) 55.8% (191/342) 61.0% (626/1026) p = 0.092
 Total gonadotrophin dose (IU), mean ± SD 2778.29 ± 866.62 2730.50 ± 1214.06 p = 0.501
 EM thickness on HCG-day (mm), mean ± SD 10.08 ± 1.57 10.78 ± 1.55 p<0.001
 E2 on hCG-day (pmol/L), mean ± SD 9661.81 ± 6011.21 9442.79 ± 5834.27 p = 0.580
 LH on hCG-day (mIU/ml), mean ± SD 2.76 ± 1.42 2.81 ± 1.47 p = 0.651
 P on hCG-day (nmol/L), mean ± SD 1.73 ± 1.79 1.62 ± 2.91 p = 0.526
 Oocytes collected, mean ± SD 13.11 ± 7.77 12.28 ± 6.02 p = 0.073
 2PN embryos, mean ± SD 7.63 ± 5.88 7.10 ± 4.60 p = 0.113
 Day-3 embryos, mean ± SD 5.24 ± 5.30 4.95 ± 4.21 p = 0.363
  1. E2 estradiol, EM endometrial, hCG human chorionic gonadotrophin, ICSI intracytoplasmic sperm injection, IVF in vitro fertilization, 2PN two pronuclear zygote, P progesterone